Here’s what you should know
1. Envision lost 28.3 percent of its value during the quarter.
2. The Fool attributes the loss to several factors. Envision revised its full-year guidance downward to reflect decreased emergency medicine volume, and Envision also agreed to sell its American Medical Response business to KKR for $2.4 billion, decreasing total portfolio holdings in the space.
3. The Fool reports investors are still bullish on the late-2016 merger of Envision and AmSurg, but admits, “the company is going through a rough patch that could continue to challenge the stock in the months ahead.”
More articles on improving performance:
Sentara closing medical center, ASC in Kitty Hawk — 6 key notes
The top 10 US cities for disabled people
After CHIP funding lapses, 9M children at risk of losing coverage — 4 insights
